As climate change accelerates, it is becoming increasingly important to study the impact of climate change on human health.
BlossomHill raises $100M in bid to repeat founders’ cancer success at Turning Point
BlossomHill Therapeutics has closed a $100 million Series B to bring three of its oncology small molecules into the clinic and collect early efficacy data